Showing results (1-10 of 278) with videos related to
Sort By:
Pageof 28
International Journal of Cancer|January 24, 2023
Managing an extension of screening intervals: Avoiding boom and bust in health care workloadsFrancesca Pesola, Matejka Rebolj, Peter SasieniJournal of Medical Screening|October 4, 2018
Is a delay in the introduction of human papillomavirus-based cervical screening affordable?Alejandra Castañon, Matejka Rebolj, Peter SasieniBritish Journal of Cancer|February 9, 2021
Recovery strategies following COVID-19 disruption to cervical cancer screening and their impact on excess diagnosesAlejandra Castanon, Matejka Rebolj, Francesca Pesola, et al.Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Evaluating the impact of age on prostate cancer overdiagnosis using long-term follow-up from a randomised trialAdam R Brentnall, Matejka Rebolj, Peter Sasieni, et al.International Journal of Cancer|April 22, 2026
Evaluating the Impact of Age on Prostate Cancer Overdiagnosis Using Long-Term Follow-Up From the CAP Randomised TrialAdam R Brentnall, Matejka Rebolj, Peter Sasieni, et al.Nature Reviews. Clinical Oncology|June 13, 2025
Promises and pitfalls of multi-cancer early detection using liquid biopsy testsJonathan C M Wan, Peter Sasieni, Nitzan RosenfeldNature Reviews. Clinical Oncology|November 11, 2009
Primary HPV screening for cervical cancer prevention: results from European trialsElsebeth Lynge, Matejka ReboljAsian Pacific Journal of Cancer Prevention : APJCP|January 29, 2010
Challenges to cervical screening in a developing country: The case of MalaysiaNor Hayati Othman, Matejka ReboljExpert Review of Anticancer Therapy|August 3, 2011
Human papillomavirus testing and genotyping in cervical screeningMatejka Rebolj, Elsebeth Lynge, Jesper BondeEuropean Journal of Cancer (Oxford, England : 1990)|September 14, 2010
False-positive Human Papillomavirus DNA tests in cervical screening: it is all in a definitionMatejka Rebolj, Igor Pribac, Elsebeth LyngePageof 28